Sage Journals: Discover world-class research

Retricted access

Research article

First published 2021-3

Medication use evaluation of the financial and clinical implications of ixazomib compared to bortezomib in the outpatient setting

Katelyn A Zink, Susan Fajardo

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2021

Accidental Ixazomib Overdose in a Patient With Multiple Myeloma

Parth J. Sampat, Maneesh Bisen, Nimisha Srivastava [...]

Journal of Investigative Medicine High Impact Case Reports

Free access

Review article

First published 2017-7

The potential of ixazomib,a second-generation proteasome inhibitor,in the treatment of multiple myeloma

Jason Brayer, Rachid Baz

Therapeutic Advances in Hematology

Open access

Case report

First published 2023

Ixazomib-induced Sweet’s syndrome: A case report

Jeanne Bellemare, Hannah Laure El Fassy, Alexandra Mereniuk

Sage Open Medical Case Reports

Open access

Case report

First published 2023-12

Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib

Martina Dameri, Alessandro Garlaschi, Paola Cuccarolo [...]

Tumori Journal

Open access

Research article

First published 2022

Ixazomib Combined With Autologous Stem Cell Transplantation for POEMS Syndrome: A Case Report and Meta-Analysis

Ji Ma, Xiaoyue Wang, Hui Lu [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2026

Real-world efficacy and tolerability of ixazomib-based combination therapies in advanced multiple myeloma and other plasma cell neoplasms

Xiang Zhou, Julia Mersi, Christine Riedhammer [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2016-5

Drug Monographs: Ixazomib and Necitumumab

Fern E. Lawson, J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Retricted access

Research article

First published 2021-6

Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials

Eric P Borrelli, Conor G McGladrigan

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2016-4

Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease

Emily Ashjian, Kimberly Redic

Journal of Oncology Pharmacy Practice

Search results